|NIGMS Strategic Plan Reinforces Commitment to
The National Institute of General Medical Sciences (NIGMS), part
of the National Institutes of Health (NIH), today issued Investing
in Discovery, a strategic plan that will guide the Institute's
decision-making over the next 5 years.
"NIGMS has a strong record of fostering discovery in a broad
range of biomedical areas, and we are dedicated to promoting a
research environment that will continue to yield important breakthroughs," said
NIGMS Director Jeremy M. Berg, Ph.D.
NIGMS supports research that increases understanding of life processes
and lays the foundation for advances in disease diagnosis, treatment,
NIGMS-funded researchers seek to answer important questions in
fields such as cell biology, biophysics, genetics, developmental
biology, pharmacology, physiology, biochemistry, chemistry, bioinformatics,
computational biology, and selected clinical and behavioral science
areas. NIGMS also provides leadership in training the next generation
of scientists to assure the vitality and continued productivity
of the research enterprise.
"This plan articulates our core principles and shows how
we will make strategic investments to maximize the benefits of
the public funds entrusted to us," Berg said.
Key features of Investing in Discovery include:
Maintaining a balanced research portfolio
Central to the plan is a commitment to investigator-initiated research,
mostly research project grants known as R01s, as the main focus
of the NIGMS portfolio. Coordinated research programs will also
provide an important avenue for addressing specific biomedical
problems and creating resources for the scientific community.
NIGMS will make special efforts to encourage and support exceptionally
innovative proposals that have the potential for significant
impact, even if they carry more than the usual element of risk.
Fostering a robust, stable, and diverse scientific workforce
One of the Institute's top priorities is nurturing a strong research
workforce that accurately reflects the U.S. population. NIGMS
is dedicated to supporting high-quality research training, facilitating
career stability, and increasing workforce diversity. The Institute
will also sustain its efforts to fund new investigators and to
provide bridge funding for highly meritorious investigators faced
with potential funding gaps.
Communicating with scientists and the public
The Institute will continue to foster an open dialogue with the
scientific community, convey its goals and research results to
the public, and advance awareness and understanding of biomedical
NIGMS developed the strategic plan during a year-long process
that featured comprehensive consultation with the scientific community
and other stakeholders. This process enabled NIGMS to examine its
values and progress and receive input from hundreds of individuals
The plan is available at http://www.nigms.nih.gov/StrategicPlan/.
To request a printed copy, send e-mail to firstname.lastname@example.org or
To interview Dr. Jeremy M. Berg about the NIGMS Strategic Plan
2008-2012, contact the NIGMS Office of Communications and Public
Liaison at 301-496-7301.
For more information on NIGMS, see http://www.nigms.nih.gov.
The National Institutes of Health (NIH) — The Nation's
Medical Research Agency — includes 27 Institutes and
Centers and is a component of the U.S. Department of Health and
Human Services. It is the primary federal agency for conducting
and supporting basic, clinical and translational medical research,
and it investigates the causes, treatments, and cures for both
common and rare diseases. For more information about NIH and
its programs, visit www.nih.gov.